Audit finds reporting delays for UPMC program cost taxpayers $120K
Per Deputy Auditor General for Audits Gordon Denlinger, this finding comes after an audit into UPMC's Community HealthChoices contract with the Pennsylvania Department of Human Services.
He explains that UPMC is required to report to the DHS when someone dies, goes to jail or is no longer eligible for the program. That information helps DHS set the rate it pays to UMPC to provide care to people on Community HealthChoices.
However, the audit found that UPMC failed to notify DHS of changes to participants' program eligibility status and didn't consistently provide Community HealthChoices participant eligibility information. As a result, DHS overplayed UPMC by $357,048 in 2022, with $120,977 of that money being unrecoverable.
'UPMC either didn't perform the required assessments to see if people were still eligible for care, or when they performed the assessments, they were done too late,' Denlinger said.
The Auditor General's Office found that UPMC needs to report changes to participants' status weekly, which is what's required.
We reached out to UPMC about the audit but have not yet heard back.
Download the FREE WPXI News app for breaking news alerts.
Follow Channel 11 News on Facebook and Twitter. | Watch WPXI NOW
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
2 days ago
- CBS News
Sucralose could make cancer treatments less effective, new study says
New research by the University of Pittsburgh and UPMC Hillman Cancer Center suggests that sucralose may be detrimental to those undergoing cancer immunotherapy. Recently published in Cancer Discovery, a peer-reviewed medical journal, the study found that patients with melanoma and non-small cell lung cancer who consumed high levels of sucralose had worse response to immunotherapy and poorer survival than those with diets low in the artificial sweetener. However, supplements that increased levels of the amino acid arginine reduced the harmful effects of sucralose on immunotherapy in mice, a strategy that may soon be explored in clinical trials. "It's easy to say, 'Stop drinking diet soda,' but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic," said lead author Abby Overacre, Ph.D., assistant professor in the Department of Immunology at Pitt and UPMC Hillman. "We need to meet patients where they are. That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy." Senior author Diwakar Davar, M.D., associate professor of medicine at Pitt and a medical oncologist and hematologist at UPMC Hillman, collaborating with Overacre and their team, used mice to show that the negative impacts of sucralose are driven by disruption to gut bacteria. Sucralose altered the composition of the gut microbiome in mice, boosting species that break down arginine. As a result, arginine levels dropped in the blood, tumor fluid, and stool. Immune checkpoint inhibitors like anti-PD1 enhance T cell activity to help them better destroy cancer cells. Arginine plays a critical role in supporting T cell function, particularly in the context of cancer. "When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly," said Overacre. "As a result, immunotherapy wasn't as effective in mice that were fed sucralose." In mouse models of lung and skin cancer, adding sucralose to the diet made anti-PD1 immunotherapy less effective, resulting in bigger tumors and shorter survival. However, when the mice were given arginine—or citrulline, which the body turns into arginine—the treatment started working again. To see if this might apply to people, the researchers studied 132 patients with advanced melanoma or lung cancer who were receiving anti-PD1 immunotherapy, either alone or with chemotherapy. These patients completed detailed diet surveys, including questions about how often they used artificial sweeteners in drinks such as coffee, tea, and diet soda. "We found that sucralose impeded the effectiveness of immunotherapies across a range of cancer types, stages and treatment modalities," said Davar. "These observations raise the possibility of designing prebiotics, such as targeted nutrient supplementation for patients who consume high levels of sucralose." With these new findings, researchers aim to launch a clinical trial to see whether citrulline supplements can influence the gut microbiome and improve the immune system's ability to fight tumors in patients. Researchers are also interested in examining how other sugar substitutes, such as aspartame, saccharin, xylitol and stevia, impact the immune system and response to immunotherapy.
CBS News
3 days ago
- CBS News
Gov. Josh Shapiro joins lawsuit suing Trump Administration over gender-affirming care
Pennsylvania Governor Josh Shapiro is joining with other state leaders to sue the Trump Administration over gender-affirming care after the U.S. Department of Justice subpoenaed several healthcare clinics and providers. More than 20 doctors and clinics that have been involved in transgender medical care were subpoenaed, and now Governor Shapiro is joining with 16 other Democratic officials suing the Trump Administration over restrictions for gender-affirming care for people under the age of 19. The federal lawsuit filed in Boston alleges that attempts to deny medically necessary healthcare to transgender people through an executive order are unlawful. According to the Department of Justice, however, these investigations include healthcare fraud, false statements, and more, saying those involved in performing these types of procedures on children will be held accountable. The lawsuit claims the Trump Administration is targeting these individuals, as well as alleging the administration has intimidated healthcare providers. It says this order is unlawful because there is no federal statute that bans providing care to minors. UPMC was among those subpoenaed along with others in Pennsylvania. "These actions have made it abundantly clear that our clinicians can no longer provide certain types of gender-affirming care without risk of criminal prosecution," a UPMC spokesperson told KDKA-TV. "This includes specific restrictions on puberty blockers and hormone therapy for individuals under 19." While it is unknown what will come from the lawsuit, UPMC has said they will continue to provide necessary healthcare within the bounds of the law.
CBS News
3 days ago
- CBS News
UPMC Hillman Academy students present findings and progress following summer program
There were some hardworking students in our area on Friday showing everyone what they've learned after eight weeks of work. It's all part of UPMC's Hillman Academy, which has been going on since 2009. Each student works with a mentor over the course of the summer program. "I've been doing this for 7 weeks, so I know what I'm talking about," Zacharias Barron, an incoming first-year student at Johns Hopkins University, said going into today's presentations. Barron recently graduated from Woodland Hills High School. His project was focused on the drug Panobinostat, which is used to treat multiple myeloma. "We're just trying to see the different amounts of that drug; on to the cancer cells, and which is more effective," he said. Another student, Caelan McCormack, is a junior at St. Lawrence University in Northern Central New York. She's originally from the Washington, D.C. area, Northern Virginia to be exact, and is attempting to stop the migration of osteosarcoma to the lungs, which happens to some patients with that form of cancer. "We think that there's a small signaling vesicle that's doing that," McCormack said. Of course, learning from mentors in the labs came with obstacles for the 84 kids, between high school and college, who participated this year. "It took me four tries to start the project," Barron said. But it's worth it. People like McCormack's dad, who survived osteosarcoma, the same disease she's studying this summer, push her. "Knowing that he survived such a rare cancer and knowing that there are so many people that haven't survived it, has really pushed me into wanting to study osteosarcoma," she said. Steven Jones, the project manager for the UPMC Hillman Academy, says they're hoping they can get more mentors in this program, which will allow them to get more students in.
